Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:RAD

Rite Aid (RAD) Stock Price, News & Analysis

Rite Aid logo

About Rite Aid Stock (NYSE:RAD)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.39
$1.89
52-Week Range
N/A
Volume
5,426 shs
Average Volume
4.16 million shs
Market Capitalization
$34.71 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive RAD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Rite Aid and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

RAD Stock News Headlines

What Steve Bannon revealed about Trump’s gold play
A Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your IRA could be at risk. Here’s how to prepare.tc pixel
See More Headlines

RAD Stock Analysis - Frequently Asked Questions

Rite Aid Co. (NYSE:RAD) issued its quarterly earnings data on Thursday, April, 20th. The company reported ($1.24) EPS for the quarter, missing analysts' consensus estimates of ($0.77) by $0.47. Rite Aid's quarterly revenue was up .5% compared to the same quarter last year.

Rite Aid shares reverse split before market open on Monday, April 22nd 2019.The 1-20 reverse split was announced on Wednesday, April 10th 2019. The number of shares owned by shareholders was adjusted after the closing bell on Friday, April 19th 2019. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Rite Aid subsidiaries include Bartell Drugs, Envision Pharmaceutical, RediClinic, Health Dialog, Edgehill Drugs, PCS Health Systems, Harco, and others.

Based on aggregate information from My MarketBeat watchlists, some other companies that Rite Aid investors own include BMO Capital Markets (), Stifel Nicolaus (), Wunderlich (), Standpoint Research (), Duncan Williams (), Soleil Securities () and Sterne Agee CRT ().

Company Calendar

Last Earnings
4/20/2023
Today
9/02/2025
Fiscal Year End
2/28/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Drug stores & proprietary stores
Sub-Industry
Drug Retail
Current Symbol
NYSE:RAD
CIK
84129
Employees
47,000
Year Founded
1968

Profitability

EPS (Trailing Twelve Months)
($17.25)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$749.94 million
Net Margins
-3.99%
Pretax Margin
-4.02%
Return on Equity
N/A
Return on Assets
-1.90%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.32
Quick Ratio
0.61

Sales & Book Value

Annual Sales
$24.09 billion
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
0.36
Book Value
($11.35) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
56,700,000
Free Float
55,800,000
Market Cap
$34.71 million
Optionable
Optionable
Beta
1.25

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NYSE:RAD) was last updated on 9/2/2025 by MarketBeat.com Staff
From Our Partners